Tag "ReActiv8"

Back to homepage
NEWS PRODUCT NEWS

Mainstay Medical obtains US approval for ReActiv8

Mainstay Medical has received US Food and Drug Administration (FDA) approval for ReActiv8, its implantable neurostimulation system to treat intractable chronic low back pain. The FDA approval grants Mainstay the